+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Molecular Glue"

Targeted Protein Degradation Market: Focus on Technology Platforms and Therapeutics: Distribution by Type of Protein degrader, Therapeutic Areas, Route of administration, Key Contributing Technologies and Key Geographies, 2021-2030 - Product Thumbnail Image

Targeted Protein Degradation Market: Focus on Technology Platforms and Therapeutics: Distribution by Type of Protein degrader, Therapeutic Areas, Route of administration, Key Contributing Technologies and Key Geographies, 2021-2030

  • Report
  • March 2021
  • 330 Pages
  • Global
From
Targeted Protein Degradation by Proteasomal, Lysosomal & Autophagy Pathways 2022: An Industry Landscape Analysis of Stakeholders, Technologies, Pipeline, Partnering and Financing - Product Thumbnail Image

Targeted Protein Degradation by Proteasomal, Lysosomal & Autophagy Pathways 2022: An Industry Landscape Analysis of Stakeholders, Technologies, Pipeline, Partnering and Financing

  • Report
  • March 2022
  • 553 Pages
  • Global
From
Precision Cancer Therapies, Volume 1. Targeting Oncogenic Drivers and Signaling Pathways in Lymphoid Malignancies: From Concept to Practice. Edition No. 1 - Product Thumbnail Image

Precision Cancer Therapies, Volume 1. Targeting Oncogenic Drivers and Signaling Pathways in Lymphoid Malignancies: From Concept to Practice. Edition No. 1

  • Book
  • May 2023
  • 512 Pages
Inducing Targeted Protein Degradation. From Chemical Biology to Drug Discovery and Clinical Applications. Edition No. 1 - Product Thumbnail Image

Inducing Targeted Protein Degradation. From Chemical Biology to Drug Discovery and Clinical Applications. Edition No. 1

  • Book
  • December 2022
  • 384 Pages
  • 4 Results (Page 1 of 1)
Loading Indicator

The Molecular Glue market is a subset of the Immune Disorders Drugs market, which focuses on treatments for conditions such as allergies, asthma, and autoimmune diseases. Molecular Glue is a type of drug that works by binding to the surface of immune cells, preventing them from attacking healthy cells. This type of drug is often used to treat conditions such as rheumatoid arthritis, psoriasis, and Crohn's disease. Molecular Glue drugs are typically administered orally or intravenously, and can be used in combination with other treatments. Molecular Glue drugs are becoming increasingly popular due to their ability to target specific cells and reduce inflammation. They are also seen as a safer alternative to traditional treatments, as they have fewer side effects. As a result, the Molecular Glue market is expected to continue to grow in the coming years. Some companies in the Molecular Glue market include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more